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 Growth in children exposed to 
early deprivation. 
 Growth suppression and recovery 
 Trajectories 
 Mechanisms 
 Factors determining final height 
 Long-term risks 
 Mental health 
 Chronic diseases 
 Life-span 
 
Nutrition Issues Specific to 
International Adoption 
Growth Failure in 
Institutionalized Children 
Growth Failure in 
Institutionalized Children 
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Profound Growth Failure In 
Institutionalized Children 
n=262 133(f) 3-19 y 
17 y girl 
14 y girl 
11 y girl 
Nutrition and Institutional Growth 
Failure 
 Available diet 
 Energy requirements are 20% higher in premature 
infants due to: 
– Higher basal metabolic rate 
– Lower coefficient of absorption for fat and 
carbohydrates 
 Ability and desire to feed 
 Indifference (hospitalism) 
 Neuromotor problems, orofacial malformations 
 Opportunity to feed 
 Not cue-based feeding—”efficiency-based” 
 Inability to absorb substrate. 
 
Summary: Growth Failure in 
Institutionalized Children 
 All growth parameters affected 
 Overall suppression rather than dose-dependent 
related to degree of deprivation. 
 Underlying medical issues (LBW, FAS) 
exacerbate growth suppression. 
 Mechanisms are somewhat age-dependent and 
involve nutrition and hypothalamic-pituitary-end 
organ suppression.  
Catch-Up Growth 
Post-Placement Catch-up Growth 
Eastern European Growth Study, U of MN 
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Summary 
Post-Placement Growth 
 Rapid- Essentially Complete after 12 Months 
 Most Dramatic Catch-up Growth 
 Younger at the Time of Arrival 
 Smaller at the Time of Arrival 
 Higher Quality Care after Arrival 
 Positive Regard 
 Sensitivity 
 Better Caloric Intake after Arrival 
 Recovery of the GH-IGF-1 axis 
 Who Lags Behind at 6 Months? 
 Those most growth suppressed at arrival. 
 Older Children 
 
   
 
 
Long Term Recovery 
Follow-up Height and Weight 
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Age at Follow-up 
Why is Final Height Impaired? 
Parental Size??? 
Prenatal growth impairment 
Postnatal growth impairment 
Earlier puberty (particularly girls) 
Sex Differences 
 Boys 
 In Utero Differentiation 
 Early Postnatal Surge 
 Dormant in Infancy 
 Pubertal Activation 
 Later than in Girls 
 Testosterone 
 Genital Changes 
 Pubic Hair 
 Testicular Size 
 Precocious Puberty < 9 years 
 Girls  
 Minimal Activity in Utero 
 Ovarian Activity Persists 
through Infancy 
 Pubertal Activation 
 Earlier by 2 years 
 Estradiol and 
Progesterone 
 Breast Changes 
 Pubic Hair 
 Menses 
 Precocious Puberty < 8 years 
Age of Pubertal Changes in 
International Adoptees vs. Danish Girls 
Teilmann, et al., Horm Res 2009;72:236-246 
9.5 (7.1-12.0) 
16% < 8 yrs 
1.3 years earlier 
10.8 (8.4-13.2) 
12.1 (10.2-14.0) 
16% < 8 yrs 
1.3 years earlier 
13.4 (10.8-16.0 
IA’s, N = 276 
Control, N = 1,100 
Management of Early Puberty 
 LHRH Agonists 
LHRH Agonists eliminate pulsatility 
Lupron 
 Depot Lupron, 3.75 to 11.25 mg im monthly 
 Desensitizes the HPG Axis 
 Does not impede Adrenal Androgen Production 
Supprelin LA Depot 
 Surgical implantation of a small plastic rod 
 Releases LHRH agonist daily over 12 months 
 Can be either removed or replaced 
LHRH Agonist Treatment 
 Successful in stopping central puberty 
 Costs $800 to $2,000 per month 
 Similar cost between Lupron and Supprelin 
 Buys additional years of childhood 
 Definite improvement in adult height when 
started before age 6 
 Lack of agreement on when to start or stop 
 No impairment of later reproductive function 
SGA vs Institutionalized Children 
 Growth Impaired early in 
life. 
 Impaired growth hormone 
secretion/sensitivity 
 Catch-up growth 
 Early puberty especially 
girls 
 Abnormalities in cortisol 
secretion 
 Metabolic Syndrome 
 Obesity 
 Type II Diabetes 
 Hypertension 
 Cardiovascular disease 
 Growth Impaired early in 
life. 
 Impaired growth hormone 
secretion/sensitivity 
 Catch-up growth 
 Early puberty especially 
girls 
 Abnormalities in cortisol 
secretion 
 Metabolic Syndrome ??? 
 Higher BMI’s 
SGA Institutionalized 
Stress and Adverse Outcomes 
13,494 Adults in Kaiser Permanente HMO 
 Exposed to: 
 Psychological Abuse 
 Physical Abuse 
 Sexual Abuse 
 Household substance 
abuse 
 Household mental illness 
 Mother treated violently 
 Household criminal 
behavior 
 
Felitti, et al, Am J Prev Med 1998; 14(4):245-258 
 ≥ 4 Categories 
 Alcoholism 7.4 
 Used elicit drugs 4.7 
 Injected drugs 10.3 
 ≥ 50 intercourse partners 3.2 
 Sexually transmitted disease 2.5 
 Ischemic heart disease 2.2 
 Cancer 1.9 
 Stroke 2.4 
 Chronic bronch/emphy 3.9 
 Diabetes 1.6 
Stress and Adverse Outcomes 
1193 Female  Adults in Kaiser Permanente HMO 
 Woman who experienced ≥ 4 exposures were 
1.5 time more likely to have an unintended first 
pregnancy. 
 Strongest associations with 
 Frequent psychological abuse 
 Frequent physical abuse of the mother by her 
partner 
 Frequent physical abuse 
 
Dietz, et al, JAMA 1999; 282(14):1259-1364 
Stress and Adverse Outcomes 
 
Felitti, et al, Am J Prev Med 1998; 14(4):245-258 
Adverse Childhood Experiences, 
Allostasis, Allostatic Load and Age-
Related Diseases 
 Brain 
 Structural alterations in brain regions responsible for 
executive function, memory and emotional tone 
 HPA Axis 
 Alterations in cortisol levels, normal diurnal variations 
and responsiveness 
 Immune System 
 Elevated inflammation levels and altered response to 
infections.  
Danese and McEwen Physiology and Behavior 2012;106:9-39 
Stress and Adverse Outcomes 
Meta-analysis of 24 studies including 48,801 individuals 
 Neurological Problems 
 Migraines 
 Musculoskeletal 
Problems  
 Arthritis, broken bones 
 Respiratory Problems 
 Asthma, bronchitis 
 Cardiovascular Problems 
 Heart attack, stroke 
 
 Gastrointestinal Disorders 
 Hernia, spastic colitis 
 Metabolic Disorders 
 Diabetes, obesity 
 Autoimmune Disorders 
 
 
 
Wegman and Stetler, Psychosomatic Medicine 71:805-812 (2009) 
Stress and Adverse Outcomes 
32 Year Prospective Study of 1037 New Zealanders 
 Children exposed to adverse psychosocial 
experiences (maltreatment, social isolation) 
during the first decade of life were at elevated 
risk of depression, high inflammation levels and 
a clustering of metabolic risk factors [≥ 3 
overweight, high blood pressure, high total 
cholesterol, low HDL cholesterol, elevated Hgb-
A1C or low maximum oxygen consumption 
levels] 
 
Dietz, et al, JAMA 1999; 282(14):1259-1364 
IAP-Follow-up Height and Weight 
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Age at Follow-up 
 Telomeres-specialized nucleoprotein complexes 
located at the end of chromosomes that 
promotes chromosomal stability.  
 Telomere length shortens with each successive 
cellular division. 
 Once teleomere length reaches a critical point, 
cell senescence is trigger, cell division ceases 
and the cell dies. 
 Accelerated telomere length shortening has 
been associated with normative aging as well as 
cigarette smoking, radiation exposure, oxidative 
stress and psychological stress including a 
history of early maltreatment.  
 
 
 
Genome-Environment Interactions 
Telomere Length and  
Institutional Care 
 Bucharest Early Intervention Project 
Telomere length at 8 years of age was 
inversely related to the length of 
institutionalization.  
Girls-length of institutionalization at 
baseline (22 months of age) 
Boys-length of institutionalization at 54 
months of age. 
 
Stress and Adverse Outcomes 
 
Felitti, et al, Am J Prev Med 1998; 14(4):245-258 
Influence of  
Adoptive Family 
